These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7626689)

  • 1. Regrowth resistance in cancer: why has it been largely ignored?
    Preisler HD; Venugopal P
    Cell Prolif; 1995 Jun; 28(6):347-56. PubMed ID: 7626689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regrowth resistance as a likely significant contributor to treatment failure in drug-sensitive neoplastic diseases.
    Preisler HD; Raza A; Bonomi P; Taylor S; LaFolette S; Leslie W; Lincoln S
    Cancer Invest; 1997; 15(4):358-68. PubMed ID: 9246159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regrowth resistance in leukemia and lymphoma: the need for a new system to classify treatment failure and for new approaches to treatment.
    Preisler HD; Gopal V
    Leuk Res; 1994 Mar; 18(3):149-60; discussion 161. PubMed ID: 7511189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New targets for cancer therapy.
    Coombes RC
    Mol Aspects Med; 1993; 14(5):373-449. PubMed ID: 8208067
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer chemotherapy.
    Secchi GC
    Ann Ital Med Int; 1990; 5(3 Pt 3):288-95. PubMed ID: 2081089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicity.
    Costa MI; Boldrini JL; Bassanezi RC
    Math Biosci; 1995 Feb; 125(2):211-28. PubMed ID: 7881195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance and behavioural phenotype of cancer cells.
    Bashir I; Sikora K; Foster CS
    Cell Biol Int; 1993 Oct; 17(10):907-17. PubMed ID: 8287021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug kinetics and drug resistance in optimal chemotherapy.
    Costa MI; Boldrini JL; Bassanezi RC
    Math Biosci; 1995 Feb; 125(2):191-209. PubMed ID: 7881194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mathematical model of drug resistance: heterogeneous tumors.
    Panetta JC
    Math Biosci; 1998 Jan; 147(1):41-61. PubMed ID: 9401351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy--theory and practice.
    Capizzi RL; Keiser LW; Sartorelli AC
    Semin Oncol; 1977 Jun; 4(2):227-53. PubMed ID: 327555
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimal control of tumor size used to maximize survival time when cells are resistant to chemotherapy.
    Martin RB; Fisher ME; Minchin RF; Teo KL
    Math Biosci; 1992 Jul; 110(2):201-19. PubMed ID: 1498450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 and response to chemotherapy and radiotherapy.
    Ruley HE
    Important Adv Oncol; 1996; ():37-56. PubMed ID: 8791127
    [No Abstract]   [Full Text] [Related]  

  • 13. Conflicting objectives in chemotherapy with drug resistance.
    Costa MI; Boldrini JL
    Bull Math Biol; 1997 Jul; 59(4):707-24. PubMed ID: 9214850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative advantage rather than classical drug resistance as the cause of treatment failure in chronic myelogenous leukemia.
    Preisler HD; Raza A; Baccarani M
    Leuk Lymphoma; 1993; 11 Suppl 1():303-6. PubMed ID: 7504547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repopulation of tumour cells between cycles of chemotherapy: a neglected factor.
    Davis AJ; Tannock JF
    Lancet Oncol; 2000 Oct; 1():86-93. PubMed ID: 11905673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor heterogeneity and drug resistance.
    Dexter DL; Leith JT
    J Clin Oncol; 1986 Feb; 4(2):244-57. PubMed ID: 3944607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for recruitment and synchronization in leukemia and solid tumors.
    Mauer AM; Murphy SB; Hayes FA
    Cancer Treat Rep; 1976 Dec; 60(12):1841-4. PubMed ID: 1026338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New thoughts on resistance to chemotherapy.
    Goldie JH
    Hosp Pract (Off Ed); 1983 May; 18(5):165-9, 173-7. PubMed ID: 6404792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Principles of chemotherapy of neoplastic diseases in children].
    Matysiak M; Ochocka M
    Pediatr Pol; 1982 Dec; 57(12):1099-105. PubMed ID: 7182789
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular interrelationships in multidrug resistance (review).
    Kellen JA
    Anticancer Res; 1994; 14(2A):433-5. PubMed ID: 8017843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.